Paper20002783
Lopinavir protein binding in HIV-1-infected pregnant women.
Aweeka FT and 10 others. HIV Med, 2010. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Lopinavir protein binding in HIV-1-infected pregnant women. Papers, record 20002783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20002783
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute-Phase Proteins | Major topic |
| HIV Infections | Major topic |
| HIV Protease Inhibitors | Major topic |
| HIV-1 | Major topic |
| Pregnancy Complications, Infectious | Major topic |
| Pyrimidinones | Major topic |
| Adolescent | |
| Adult | |
| Antiretroviral Therapy, Highly Active | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Lopinavir | |
| Pregnancy | |
| Pregnancy Trimester, Third | |
| Prospective Studies | |
| Protein Binding | |
| Ritonavir | |
| Young Adult |
Source PubMed
Grants13
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01-HD-031318-11 | NICHD NIH HHS | United States | U01HD031318 | PubMed and NIH | NIH RePORTER |
| U01 AI068632 | NIAID NIH HHS | United States | U01AI068632 | PubMed and NIH | NIH RePORTER |
| M01 RR000533 | NCRR NIH HHS | United States | M01RR000533 | PubMed and NIH | NIH RePORTER |
| U01 HD031318 | NICHD NIH HHS | United States | U01HD031318 | PubMed and NIH | NIH RePORTER |
| M01 RR001271 | NCRR NIH HHS | United States | M01RR001271 | PubMed and NIH | NIH RePORTER |
| UM1 AI069477 | NIAID NIH HHS | United States | U01AI069477 | PubMed and NIH | NIH RePORTER |
| U01 AI068616 | NIAID NIH HHS | United States | U01AI068616 | PubMed and NIH | NIH RePORTER |
| M01 RR00533 | NCRR NIH HHS | United States | M01RR000533 | PubMed and NIH | NIH RePORTER |
| U01AI068632 | NIAID NIH HHS | United States | U01AI068632 | PubMed and NIH | NIH RePORTER |
| 5 M01 RR01271 | NCRR NIH HHS | United States | M01RR001271 | PubMed and NIH | NIH RePORTER |
| 1 U01 AI068616 | NIAID NIH HHS | United States | U01AI068616 | PubMed and NIH | NIH RePORTER |
| N01-HD-3-3365 | NICHD NIH HHS | United States | PubMed | PubMed | |
| UM1AI069477 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00042289 | Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy | Results |
Source ClinicalTrials.gov
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,749,369 | Plasma protein binding of drugs in pregnancy. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/6749369 | PubMed |
| 2 | 6,600,623 | Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. | Br J Obstet Gynaecol | 1983 | https://conductscience.org/library/papers/6600623 | PubMed |
| 3 | 7,413,726 | Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. | Pharmacol Ther | 1980 | https://conductscience.org/library/papers/7413726 | PubMed |
| 4 | 18,989,231 | Lopinavir exposure with an increased dose during pregnancy. | J Acquir Immune Defic Syndr | 2008 | https://conductscience.org/library/papers/18989231 | PubMed |
| 5 | 19,439,488 | Binding of lopinavir to human alpha1-acid glycoprotein and serum albumin. | Drug Metab Dispos | 2009 | https://conductscience.org/library/papers/19439488 | PubMed |
| 6 | 16,880,170 | HIV pharmacology: barriers to the eradication of HIV from the CNS. | HIV Clin Trials | 2006 | https://conductscience.org/library/papers/16880170 | PubMed |
| 7 | 16,420,257 | Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions. | HIV Med | 2006 | https://conductscience.org/library/papers/16420257 | PubMed |
| 8 | 2,178,848 | Plasma protein binding of drugs in pregnancy and in neonates. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2178848 | PubMed |
| 9 | 7,471,620 | Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. | Clin Pharmacol Ther | 1981 | https://conductscience.org/library/papers/7471620 | PubMed |
| 10 | 16,954,724 | The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. | AIDS | 2006 | https://conductscience.org/library/papers/16954724 | PubMed |
| 11 | 16,330,496 | Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. | J Pharmacol Exp Ther | 2006 | https://conductscience.org/library/papers/16330496 | PubMed |
| 12 | 6,538,287 | Renal function and therapeutic concentrations of phenytoin. | Neurology | 1984 | https://conductscience.org/library/papers/6538287 | PubMed |
| 13 | 16,988,514 | Reduced lopinavir exposure during pregnancy. | AIDS | 2006 | https://conductscience.org/library/papers/16988514 | PubMed |
| 14 | 15,696,014 | Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. | Am J Obstet Gynecol | 2005 | https://conductscience.org/library/papers/15696014 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,323,543 | Maternal-Fetal Physiologically Based Population Pharmacokinetics Model Development of Lopinavir/Ritonavir in HIV/HBV Co-infected Pregnant Women to Quantitatively Describe the Gestational PK Characteristics and Predict the Potential Disease-Drug-Drug Interaction (DDDI). | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/40323543 | PubMed |
| 36,916,944 | Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/36916944 | PubMed |
| 34,722,417 | Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34722417 | PubMed |
| 32,798,276 | Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy. | J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/32798276 | PubMed |
| 28,391,404 | Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/28391404 | PubMed |
| 27,802,281 | Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review. | PLoS Med | 2016 | https://conductscience.org/library/papers/27802281 | PubMed |
| 27,069,778 | Model-Based Analysis of Unbound Lopinavir Pharmacokinetics in HIV-Infected Pregnant Women Supports Standard Dosing in the Third Trimester. | CPT Pharmacometrics Syst Pharmacol | 2016 | https://conductscience.org/library/papers/27069778 | PubMed |
| 26,878,071 | PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150. | Jacobs J AIDS HIV | 2015 | https://conductscience.org/library/papers/26878071 | PubMed |
| 26,525,798 | No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected Subjects. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26525798 | PubMed |
| 26,149,996 | Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26149996 | PubMed |
| 25,950,206 | Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women. | J Acquir Immune Defic Syndr | 2015 | https://conductscience.org/library/papers/25950206 | PubMed |
| 25,407,158 | Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. | HIV Med | 2015 | https://conductscience.org/library/papers/25407158 | PubMed |
| 24,038,035 | Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda. | J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24038035 | PubMed |
| 23,335,197 | Etravirine in CSF is highly protein bound. | J Antimicrob Chemother | 2013 | https://conductscience.org/library/papers/23335197 | PubMed |
| 23,274,970 | Interpreting tacrolimus concentrations during pregnancy and postpartum. | Transplantation | 2013 | https://conductscience.org/library/papers/23274970 | PubMed |
| 23,221,983 | Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines. | J Acquir Immune Defic Syndr | 2013 | https://conductscience.org/library/papers/23221983 | PubMed |
| 23,018,528 | Pharmacokinetic optimization of antiretroviral therapy in pregnancy. | Clin Pharmacokinet | 2012 | https://conductscience.org/library/papers/23018528 | PubMed |
| 22,852,073 | Global HIV/AIDS Clinical and Translational Pharmacology. | AIDS Res Treat | 2012 | https://conductscience.org/library/papers/22852073 | PubMed |
| 22,106,215 | Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22106215 | PubMed |
| 20,625,263 | Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy. | AIDS | 2010 | https://conductscience.org/library/papers/20625263 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5,243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CYP3A4 | 1,576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
Drugs40
The drugs whose trials, in the Pipelines release, list the paper.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20002783
GET https://conductscience.org/api/papers/v1/20002783/drugs?page=2